Outset Medical, Inc.

For the period ended Sep 30, 2026. Filed Nov 4, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 4, 2026

OM$4.23+3.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations

(in thousands, except per share amounts)

Three Months Ended · Nine Months Ended
	September 30,		September 30,
	2026	2025	2026	2025
Revenue:
Product revenue	$23,694	$20,558	$64,152	$64,934
Service and other revenue	9,902	8,873	28,942	25,668
Total revenue	33,596	29,431	93,094	90,602
Cost of revenue:
Cost of product revenue	13,233	11,169	33,865	33,962
Cost of service and other revenue	6,692	6,672	20,181	22,117
Total cost of revenue	19,925	17,841	54,046	56,079
Gross profit	13,671	11,590	39,048	34,523
Operating expenses:
Research and development	5,898	5,376	16,966	16,180
Sales and marketing	11,736	13,550	37,167	41,482
General and administrative	8,306	8,477	29,779	25,938
Total operating expenses	25,940	27,403	83,912	83,600
Loss from operations	(12,269)	(15,813)	(44,864)	(49,077)
Interest income and other income, net	1,241	1,855	4,122	5,734
Interest expense	(3,505)	(3,476)	(10,316)	(10,511)
Loss on extinguishment of term loan	—	—	—	(7,685)
Loss before provision for income taxes	(14,533)	(17,434)	(51,058)	(61,539)
Provision for income taxes	153	404	590	623
Net loss	$(14,686)	$(17,838)	$(51,648)	$(62,162)
Net loss per share, basic and diluted	$(0.78)	$(1.00)	$(2.78)	$(4.37)
Shares used in computing net loss per share, basic and diluted	18,831	17,783	18,609	14,228

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.